# EIP Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eip-pharma

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.eippharma.com
- Total disclosed funding: $21M
- Latest round: Series B (Apr 13, 2018)
- Investors on record: 1

## About

Founded in 2010 and based in Massachusetts, US, EIP Pharma, Inc. operates as a biotechnology company that develops therapeutic solutions to treat Alzheimer’s disease and other CNS disorders. The company offers Neflamapimod, a brain-penetrant, small-molecule oral inhibitor of p38 alpha for the treatment of Alzheimer's disease.

## Funding rounds

- Series B, Apr 13, 2018, $21M — Access Industries

## Investors

- Access Industries (https://capitalatlas.ai/funds/access-industries) — Series B